PATENT CLAIM ANALYSIS

Application Number: 15921380
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "563000"]

Abstract:
Methods of modulating a miRNA level, such as a miR-29c and/or miR-200c level, in a cell are provided. Aspects of the methods include contacting the cell with an anti-fibrotic miRNA modulating active agent, such as a tranilast active agent. Also provided are compositions for use in practicing the methods. The methods and compositions find use in a variety of applications, including the treatment of fibrotic disorders, such as a uterine leiomyoma.

Claim (Index 13):
The method according to  claim 11 , wherein the cellular miRNA is selected from the group consisting of miR-29c, miR-200c and combinations thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.81818
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14215959', '13504696', '14409953', '12671445', '14848085']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7870985255345331
- 35 USC 102 Novelty (BERT): 0.5066051819598345
- Combined Prediction Score: 0.7590491911770633
- Mean Citation Score: 198.049632
- Max Citation Score: 207.00694
- Similarity Product: 118.63659666616796

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test